Remove drug-discovery
article thumbnail

Use RAG for drug discovery with Knowledge Bases for Amazon Bedrock

AWS Machine Learning

In this post, we demonstrate how to build a RAG workflow using Knowledge Bases for Amazon Bedrock for a drug discovery use case. It then employs a language model to generate a response by considering both the retrieved documents and the original query. This data is information rich but can be vastly heterogenous.

article thumbnail

Best practices for AI and ML use across the drug discovery and development lifecycle

Clarivate

The speed and accuracy of drug discovery and development are being transformed by AI and machine learning (ML) applications. Interviews with experts across Clarivate surfaced a list of best practices for the use of AI/ML in drug discovery and development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Healx uses AI to transform rare disease drug discovery [PODCAST]

Clarivate

In this episode of Conversations in Healthcare , Dr. Tim Guilliams discusses Healx’s innovative approach to tackling rare disease drug discovery. Mike and Tim discuss the company’s innovative approach to drug discovery, choosing which rare diseases to target and how patients are shaping their priorities.

article thumbnail

Drug repurposing, real world data and AI/ML: perspectives and opportunities

Clarivate

De-novo drug discovery and development pipelines are time-consuming and costly. It can take up to 17 years and cost more than $2 billion dollars from the discovery of a new drug until it reaches the market. drug-disease pairs) and features (drug, target, and disease properties).

Data 59
article thumbnail

AWS at NVIDIA GTC 2024: Accelerate innovation with generative AI on AWS

AWS Machine Learning

AWS HealthOmics with the NVIDIA BioNeMo platform will accelerate generative AI in biology and drug discovery. (To (To learn more, see Optimize price-performance of LLM inference on NVIDIA GPUs using the Amazon SageMaker integration with NVIDIA NIM Microservices.)

article thumbnail

Generative AI’s potential to speed delivery of improved patient outcomes

Clarivate

At the same time, there are some obvious potential use cases that could significantly speed up drug development and better ensure that the right medicines reach the right patients, improving outcomes. billion (read our recent report on biopharma dealmaking to learn more about activity in this space).

article thumbnail

Bioinfogate becomes Clarivate

Clarivate

The move further expands and integrates drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle. OFF-X is already integrated with several Cortellis products, including Cortellis Drug Discovery Intelligence and Cortellis Competitive Intelligence.

Analysis 110